Join

Compare · LUNG vs RMD

LUNG vs RMD

Side-by-side comparison of Pulmonx Corporation (LUNG) and ResMed Inc. (RMD): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both LUNG and RMD operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
  • RMD is the larger of the two at $28.02B, about 445.2x LUNG ($62.9M).
  • Over the past year, LUNG is down 57.1% and RMD is down 22.4% - RMD leads by 34.6 points.
  • Both names hit the wire about 6 times in the past 4 weeks.
  • RMD has more recent analyst coverage (25 ratings vs 17 for LUNG).
PerformanceLUNG-57.06%RMD-22.43%
2025-06-09+0.00%2026-06-09
MetricLUNGRMD
Company
Pulmonx Corporation
ResMed Inc.
Price
$1.46-2.67%
$194.80+0.82%
Market cap
$62.9M
$28.02B
1M return
+15.87%
-5.80%
1Y return
-57.06%
-22.43%
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Exchange
NASDAQ
NYSE
IPO
2020
News (4w)
6
6
Recent ratings
17
25
LUNG

Pulmonx Corporation

Pulmonx Corporation, a medical technology company, designs, develops, manufactures, and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

RMD

ResMed Inc.

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides U-Sleep, which enables automated patient coaching through a text, email, or interactive voice phone call; AirView that enables remote monitoring, over-the-air trouble shooting, and changing of device settings; and myAir, a patient engagement application that offers sleep data and a daily score based on their previous night's data, as well as connectivity module and propeller solutions. In addition, it provides business management software and services to out-of-hospital providers, home medical equipment, pharmacy, home infusion, orthotics, and prosthetics; and HEALTHCAREfirst and MatrixCare solutions. The company markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Latest LUNG

Latest RMD